Core Laboratories (NYSE:CLB) Updates Q1 2025 Earnings Guidance

Core Laboratories (NYSE:CLB) updated its first quarter 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 0.120-0.160 for the period, compared to the consensus earnings per share estimate of 0.210. The company issued revenue guidance of $121.0 million-$127.0 million, compared to the consensus revenue estimate of $131.7 million.

Core Laboratories Price Performance

Shares of CLB traded down $0.01 during midday trading on Wednesday, reaching $18.52. The stock had a trading volume of 364,199 shares, compared to its average volume of 271,050. The company has a market capitalization of $869.42 million, a price-to-earnings ratio of 28.49, a price-to-earnings-growth ratio of 1.14 and a beta of 2.39. The company has a current ratio of 2.48, a quick ratio of 1.79 and a debt-to-equity ratio of 0.55. Core Laboratories has a 12-month low of $13.82 and a 12-month high of $25.13. The company’s 50-day moving average is $19.04 and its 200 day moving average is $19.50.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 EPS for the quarter, meeting analysts’ consensus estimates of $0.23. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. On average, equities analysts predict that Core Laboratories will post 0.8 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms have issued reports on CLB. StockNews.com upgraded shares of Core Laboratories from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Citigroup dropped their target price on Core Laboratories from $15.00 to $14.00 and set a “sell” rating for the company in a report on Thursday, October 31st. Two investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the company’s stock. Based on data from MarketBeat.com, Core Laboratories currently has an average rating of “Hold” and an average target price of $17.00.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.